 |
Recombinant protein derived from the saliva of theOrnithodoros moubatatick |
|---|---|
| Trade Name | |
| Orphan Indication | Guillain-Barré syndrome |
| EU Market Approval | EU |
| EU Designation Date | 2016-06-27 00:00:00 |
| Sponsor | Akari Therapeutics Plc |
| |
Recombinant protein derived from the saliva of theOrnithodoros moubatatick |
|---|---|
| Trade Name | |
| Orphan Indication | Guillain-Barré syndrome |
| EU Market Approval | EU |
| EU Designation Date | 2016-06-27 00:00:00 |
| Sponsor | Akari Therapeutics Plc |